cvs health glp-1 receptor agonists weight management diabetes treatments Caremark is adding Zepbound, Eli Lilly's obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk's Wegovy. MORE GLP-1 prescriptions for weight loss
Description
Unlike traditional diabetes drugs, GLP-1 therapies are often intended for long-term or even lifelong use

There were 632 participants with T2DM and insufficient glycemic controldefined as an A1C between 7.0% and 9.5%despite lifestyle interventions alone or treatment with a stable dose of metformin

Theranostics 11 , 22472262 (2021)
.png)
J., Chutuape, M
